A Web-Based Multimedia Resource for Prescription Opiate Treatment

描述（由申请人提供）：处方阿片类药物治疗的基于网络的多媒体资源：流行病学数据清楚地表明，滥用处方阿片类药物是一个主要的公共卫生问题。丁丙诺啡是一种重要的药物，在治疗依赖处方阿片类药物的患者方面具有很大的前景。人们普遍认为，丁丙诺啡的成功治疗涉及丁丙诺啡和心理社会咨询/治疗支持的组合。然而，越来越多的证据表明，许多正在接受丁丙诺啡治疗的处方阿片类药物成瘾者不参加任何形式的咨询或治疗。不参与咨询和治疗的原因包括此类服务的额外费用，难以获得有关使用丁丙诺啡的咨询专业人员，以及寻找时间参加治疗计划的后勤挑战。世界媒体集团（EOW）的眼睛，与加州大学洛杉矶分校综合药物滥用计划（ISAP）合作，建议开发一个创新的基于网络的资源，以增加处方阿片类药物使用者的丁丙诺啡治疗。此应用程序建议开发内部处方药物滥用（IPDA），一个基于Web的多媒体资源处方阿片类药物治疗。IPDA利用互联网技术的最新进展，将交互式视频模块、流式视频/动画片段、测验、在线论坛和其他资源汇集在一个定制网站中，使参与者能够控制何时、何地以及如何体验治疗相关内容。这些媒体工具将传达引人入胜、科学准确的信息，提供基于认知行为疗法原则的行为治疗练习，并通过互动反馈和参与工具促进康复活动。该项目团队将联合收割机的媒体专业知识，由艾米丽迈尔斯，MBA和玛丽莎Murgatroyd，MA，与一个团队的成瘾专家从加州大学洛杉矶分校ISAP领导的拉里萨穆尼，医学博士。该团队将开发内容，视频和网站应用程序，为丁丙诺啡治疗的患者创建独特的资源。将从两个重要的潜在消费者群体（丁丙诺啡处方MD（N = 50）以及目前接受丁丙诺啡治疗的患者（N = 50））中收集有关IPDA资源价值的数据。将通过焦点小组、评级量表和问卷调查收集数据，内容涉及IPDA资源的感知有用性、网站上呈现的材料的相关性和准确性、创新视频场景的吸引力和好处以及对定价、营销和促销工作的反馈。多媒体网络平台的使用是创新的，有证据表明这种产品具有商业前景。IPDA的第二阶段对照试验评价将在第一阶段项目成功之后进行。 公共卫生相关性：开发一种可获得的、具有成本效益的网络资源，以加强对处方阿片类药物依赖者的丁丙诺啡治疗，将改善这一患者群体的治疗反应，并降低与处方阿片类药物成瘾相关的发病率和死亡率。这种干预允许丁丙诺啡治疗中的患者访问一组基于Web的多媒体资源，包括交互式视频、动画、测验、定制反馈工具和其他资源，这些资源促进（a）与认知行为疗法的原理一致的知识和技能，（B）丁丙诺啡的益处，和（c）支持积极恢复活动的其他重要成瘾知识。如果成功，该产品有可能减少心理支持的重大地理，时间和财务障碍;提供关键的行为和成瘾知识;并改善数千名阿片类药物依赖者的治疗结果。

DESCRIPTION (provided by applicant): A Web-Based Multimedia Resource for Prescription Opiate Treatment: Epidemiological data clearly indicate that the abuse of prescription opiates is a major public health problem. Buprenorphine is an important medication that offers great promise in treating individuals who have become dependent on prescription opiates. It is widely accepted that successful treatment with buprenorphine involves a combination of buprenorphine and psychosocial counseling/therapy support. However, there is growing evidence that many individuals addicted to prescription opiates who are being treated with buprenorphine do not participate in any form of counseling or therapy. Reasons cited for non-participation in counseling and therapy include added cost of such services, difficulty in accessing counseling professionals with knowledge about the use of buprenorphine, and logistical challenges in finding time to attend therapy programs. Eyes of the World Media Group (EOW), in collaboration with UCLA Integrated Substance Abuse Programs (ISAP), proposes to develop an innovative Web-based resource to augment buprenorphine treatment of prescription opiate users. This application proposes to develop Inside Prescription Drug Abuse (IPDA), a Web- based multimedia resource for prescription opiate treatment. IPDA uses recent advances in Internet technology to bring together interactive video modules, streaming video/animation segments, quizzes, an online forum, and other resources in a customized Website that allows participants to control when, where, and how they experience treatment-related content. These media tools will convey engaging, scientifically accurate information, provide behavioral treatment exercises based on cognitive behavioral therapy principles, and promote recovery activities via interactive feedback and engagement tools. The project team will combine the media expertise of EOW led by Emily Meyers, MBA, and Marisa Murgatroyd, MA, with a team of addiction experts from UCLA ISAP led by Larissa Mooney, MD. This team will develop the content, video, and Website applications to create a unique resource for patients in buprenorphine treatment. Data will be collected on the value of the IPDA resource from two important potential consumer groups, buprenorphine-prescribing MDs (N=50) as well as patients (N=50) currently in treatment with buprenorphine. Data will be collected via focus groups, rating scales, and questionnaires on the perceived usefulness of the IPDA resource, the relevance and accuracy of the material presented on the site, the appeal and benefit of the innovative video scenarios, and feedback on pricing, marketing, and promotion efforts. The use of the multimedia Web platform is innovative, and there is evidence of commercial promise with such a product. A Phase II controlled trial evaluation of IPDA would follow a successful Phase I project. PUBLIC HEALTH RELEVANCE: The development of an accessible and cost-effective Web-based resource to augment the buprenorphine treatment of individuals dependent on prescription opiates will improve the treatment response of this patient group and reduce the morbidity and mortality associated with prescription opiate addiction. This intervention allows patients in buprenorphine treatment access to a set of Web-based multi-media resources comprising interactive videos, animations, quizzes, customized feedback tools, and other resources promoting (a) knowledge and skills consistent with the principles of cognitive behavioral therapy, (b) the benefits of buprenorphine, and (c) other important addiction knowledge to support positive recovery activities. If successful, the product has the potential to reduce significant geographic, temporal, and financial barriers to psychosocial support; provide critical behavioral and addiction knowledge; and improve the treatment outcomes of thousands of opioid-dependent individuals.